ICHORtec

ICHORtec GmbH is a German biotechnology company founded in 2020 that specializes in molecular precision technologies. Its core innovation is the Quantum Fluorimetry of Molecular Binding (Q-FMB) platform, which quantifies molecular interactions by measuring changes in Gibbs free energy (ΔG) through fluorescence photon analysis. By shifting from traditional fluorescence intensity measurements to energy-based thermodynamics, the platform provides high accuracy in differentiating molecular matches from mismatches. The technology is developed for diverse applications, including point-of-care diagnostics, CRISPR guide RNA design, precision medicine, and agricultural research.

The company's work is significant for addressing challenges in therapeutic safety and clinical diagnostics. By enabling direct energy measurements, the Q-FMB platform helps minimize off-target effects in gene editing and improves the reliability of molecular testing. ICHORtec is actively collaborating with academic institutions, such as the Johns Hopkins University School of Medicine, to advance CRISPR specificity and safety. In addition to its research and development services, the company is preparing to launch point-of-care diagnostic kits for conditions like MRSA and tuberculosis, aiming to improve cost and time efficiency in medical settings.